Top Story

Adjustable gastric band feasible for treatment of type 2 diabetes, obesity

Adjustable gastric band feasible for treatment of type 2 diabetes, obesity
April 28, 2015

Patients with type 2 diabetes and obesity achieved similar 1-year benefits on diabetes control, cardiometabolic risk and patient satisfaction when undergoing laparoscopic adjustable gastric band or an intensive diabetes medical and weight management program, according to recent research.

Allison B. Goldfine, MD, of head of Joslin Diabetes Center section of clinical research and associate professor of medicine at Harvard Medical School, and colleagues conducted a 12-month prospective, randomized clinical trial to evaluate the effects of laparoscopic adjustable gastric band (LAGB; n=18) and an intensive diabetes medical and weight management program (IMWM; n = 22). Participants were aged 21 to 65 years, had a BMI of 30 to 45 kg/m2, a diagnosis of type 2 diabetes more than 1 year before the study period and HbA1c of 6.5% or more on anti-hyperglycemic medications.

In the Journals

Additive genetic effects may influence circulating periostin, contribute to bone fragility

April 27, 2015
Shared genetic factors may influence serum periostin and sclerostin levels, contributing to the heritability of bone microstructure, according to research in The
Medicare’s new payment system gives physicians two options Health Care Legislative and Regulatory Update

Medicare’s new payment system gives physicians two options

April 27, 2015
The Medicare Access and CHIP Reauthorization Act, signed into law on April 16, will make major changes in Medicare payments for physician services. Things start out…
VIDEO: Diet and lifestyle changes are key to managing PCOS Meeting News CoverageVideo

VIDEO: Diet and lifestyle changes are key to managing PCOS

April 27, 2015
PHILADELPHIA — Angela Grassi, MS, RD, LDN, founder of the PCOS Nutrition Center in Philadelphia, explains that polycystic ovary syndrome management requires good…
In the Journals

Three-year postoperative surveillance cost-effective for patients with low-risk papillary thyroid cancer

April 27, 2015
Compared with annual surveillance, postoperative surveillance every 3 years, after 5 years of annual surveillance is projected to be cost-effective in patients with…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 3

Obesity Consults: Volume 2, Number 3
Biology and Behavior

This activity is supported by an educational grant from Vivus, Inc and Eisai Co., Ltd.

Obesity is a complex, multifactorial disease. Understanding how psychology, genetics, biology and neurobiology…
More »
Meeting News Coverage Video
VIDEO: Name change sought for PCOS

VIDEO: Name change sought for PCOS

April 27, 2015
PHILADELPHIA — Anuja Dokras, MD, PhD, director of the PENN Polycystic Ovary Syndrome Center in the University of…
More »
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Current Issues
View the Current Issues